Showing results (51-60 of 60) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
BMJ Open|June 18, 2024
Flow cytometric analysis of peripheral blood neutrophil myeloperoxidase expression in myelodysplastic neoplasms (MPO-MDS-Valid): protocol for a multicentre diagnostic accuracy studyCharlotte Planta, Caroline Bret, Delphine Manzoni, et al.World Journal of Stem Cells|January 12, 2018
High frequency of CD34+CD38-/low immature leukemia cells is correlated with unfavorable prognosis in acute myeloid leukemiaAdriana Plesa, Charles Dumontet, Eve Mattei, et al.Oncotarget|August 19, 2015
Oncogene- and drug resistance-associated alternative exon usage in acute myeloid leukemia (AML)Aminetou Mint Mohamed, Marie Balsat, Morgan Thenoz, et al.Immunology Letters|October 19, 2010
Mutual benefits of B-ALL and HLDA/HCDM HLDA 9th Barcelona 2010Gilbert C Faure, Sophie Amsellem, Christine Arnoulet, et al.Leukemia Research|February 8, 2017
TET2 exon 2 skipping is an independent favorable prognostic factor for cytogenetically normal acute myelogenous leukemia (AML): TET2 exon 2 skipping in AMLAminetou Mint Mohamed, Marie Balsat, Catherine Koering, et al.Leukemia|September 16, 2020
Prognostic value of high-sensitivity measurable residual disease assessment after front-line chemoimmunotherapy in chronic lymphocytic leukemiaRémi Letestu, Abdelmalek Dahmani, Marouane Boubaya, et al.Blood Advances|April 7, 2023
A fixed-duration immunochemotherapy approach in CLL: 5.5-year results from the phase 2 ICLL-07 FILO trialAnne-Sophie Michallet, Rémi Letestu, Magali Le Garff-Tavernier, et al.Ebiomedicine|June 1, 2022
Dynamics of circulating calprotectin accurately predict the outcome of moderate COVID-19 patientsNicolas Chapuis, Nusaibah Ibrahimi, Thibaut Belmondo, et al.Cytometry. Part a : the Journal of the International Society for Analytical Cytology|August 1, 2019
Standardization of Flow Cytometric Immunophenotyping for Hematological Malignancies: The FranceFlow Group ExperienceFrançoise Solly, Fanny Angelot-Delettre, Michel Ticchioni, et al.Blood Advances|December 24, 2019
How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?Francine Garnache-Ottou, Chrystelle Vidal, Sabeha Biichlé, et al.Pageof 6